Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$1.51
-0.1%
$1.65
$1.35
$5.00
$3.96M1.888,533 shs275 shs
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
$4.35
-2.0%
$3.82
$2.70
$11.60
$8.66M2.2643,342 shs1,649 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.50
+2.9%
$3.86
$1.79
$5.38
$57.37M0.91146,635 shs6,709 shs
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$0.56
+3.7%
$0.50
$0.26
$1.14
$19.63M1.5832,127 shs568 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
+5.73%+5.00%-11.58%-24.03%-71.37%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
-0.22%+29.91%+9.88%+49.51%-59.86%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+0.29%+6.25%-9.81%-3.41%-29.90%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
+1.89%+8.54%+8.43%+3.85%-48.43%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.3097 of 5 stars
3.53.00.00.01.10.00.6
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.9491 of 5 stars
3.55.00.00.01.80.81.3
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
0.9252 of 5 stars
2.03.00.00.02.61.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
3.00
Buy$10.00562.25% Upside
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$7.50114.29% Upside
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/AN/A$3.80578.57% Upside

Current Analyst Ratings

Latest NURO, AEMD, SRTS, and SSKN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/4/2024
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$23.00 ➝ $10.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$570K6.94N/AN/A$6.56 per share0.23
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
$5.90M1.47N/AN/A$13.18 per share0.33
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$24.41M2.35$0.06 per share58.71$2.98 per share1.17
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$33.36M0.59N/AN/A$0.37 per share1.51

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$12.03M-$4.99N/AN/AN/AN/A-106.28%-86.60%6/26/2024 (Estimated)
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
-$6.53M-$6.23N/AN/A-110.64%-31.31%-29.32%5/1/2024 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$490K$0.03116.71N/A1.99%1.04%0.93%5/9/2024 (Confirmed)
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
-$10.83M-$0.31N/AN/AN/A-32.47%-52.50%-17.66%5/20/2024 (Estimated)

Latest NURO, AEMD, SRTS, and SSKN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.04N/A+$0.04N/AN/AN/A  
3/27/2024Q4 2023
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/A-$0.04-$0.04$0.03N/A$8.69 million
2/22/2024Q4 2023
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/A-$1.43-$1.43-$1.43N/A$1.32 million    
2/14/2024Q3 2024
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$1.23-$1.37-$0.14-$1.37N/AN/A
2/8/2024Q4 2023
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.12$0.26+$0.14$0.26$12.10 million$12.57 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/AN/AN/AN/AN/A
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/A
3.93
3.93
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
N/A
16.80
15.55
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
11.76
8.23
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
1.19
1.28
1.06

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.99%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
19.40%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
32.43%

Insider Ownership

CompanyInsider Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
4.00%
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
4.40%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
11.10%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
40.43%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
152.62 million2.52 millionOptionable
NeuroMetrix, Inc. stock logo
NURO
NeuroMetrix
261.99 million1.90 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3516.39 million14.57 millionOptionable
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
9935.06 million20.89 millionNot Optionable

NURO, AEMD, SRTS, and SSKN Headlines

SourceHeadline
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
globenewswire.com - April 23 at 8:30 AM
STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52
americanbankingnews.com - April 23 at 3:20 AM
STRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11STRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11
msn.com - April 18 at 12:46 AM
STRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in AsiaSTRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in Asia
msn.com - April 10 at 7:44 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
finanznachrichten.de - April 9 at 2:16 PM
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanSTRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
globenewswire.com - April 9 at 8:30 AM
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2023 Earnings Call TranscriptSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - April 1 at 7:34 PM
STRATA Skin Sciences Unveils 2023 Financial Results: A Look into an Evolving Business ModelSTRATA Skin Sciences Unveils 2023 Financial Results: A Look into an Evolving Business Model
msn.com - March 31 at 6:32 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
finanznachrichten.de - March 29 at 3:08 PM
Earnings Preview For Strata Skin SciencesEarnings Preview For Strata Skin Sciences
benzinga.com - March 28 at 10:35 PM
Q4 2023 STRATA Skin Sciences Inc Earnings CallQ4 2023 STRATA Skin Sciences Inc Earnings Call
finance.yahoo.com - March 28 at 8:26 AM
Recap: Strata Skin Sciences Q4 EarningsRecap: Strata Skin Sciences Q4 Earnings
benzinga.com - March 27 at 5:25 PM
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsSTRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
globenewswire.com - March 27 at 4:01 PM
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
globenewswire.com - March 13 at 8:00 AM
Spearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin TreatmentsSpearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin Treatments
msn.com - March 11 at 6:59 PM
STRATA Skin Sciences Announces Initiative to Expand Treatment CoverageSTRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
globenewswire.com - March 7 at 8:00 AM
SSKN STRATA Skin Sciences, Inc.SSKN STRATA Skin Sciences, Inc.
seekingalpha.com - March 3 at 12:43 PM
STRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic InitiativesSTRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic Initiatives
msn.com - February 29 at 2:54 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
finanznachrichten.de - February 27 at 10:35 AM
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialSTRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
globenewswire.com - February 26 at 4:01 PM
Strata Skin Sciences Inc SSKNStrata Skin Sciences Inc SSKN
morningstar.com - February 22 at 7:35 AM
STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?
finance.yahoo.com - January 11 at 10:36 AM
STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 ConferenceSTRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference
finance.yahoo.com - January 8 at 8:23 AM
STRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid RequirementSTRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
finance.yahoo.com - January 3 at 10:15 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aethlon Medical logo

Aethlon Medical

NASDAQ:AEMD
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
NeuroMetrix logo

NeuroMetrix

NASDAQ:NURO
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Sensus Healthcare logo

Sensus Healthcare

NASDAQ:SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
STRATA Skin Sciences logo

STRATA Skin Sciences

NASDAQ:SSKN
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.